ClinicalTrials.Veeva

Menu

Diagnosis and Management of Enhanced Myometrial Vascularity Associated With Retained Products of Conception (EMV RPOC AVM)

University Hospital Center (CHU) logo

University Hospital Center (CHU)

Status

Completed

Conditions

Hypervascularized Uterine Retentions

Study type

Observational

Funder types

Other

Identifiers

NCT04176679
RECHMPL19_0532

Details and patient eligibility

About

Background:

Hypervascularized products of conception remain a topic debated in terms of definitions (ultrasound criteria, need complement by angio MRI) and management. The different uterine vascular lesions are often confused. This is a recurrent problem and care are heterogeneous. The aim of the study is to evaluate the management of these entities in CHU of Montpellier and determine more homogeneous care. The investigators further aimed to evaluate clinical presentation, ultrasound criteria, complications and the gynaecological and obstetrical outcomes of patients •Methods: This study will be conducted in compliance of ethic comitee. The investigators will collect data from 64 individuals, aged 18 to 50, suffering from uterine vascular lesions associated or not with products of conception between 2013 and 2019. Caracterisitics of the population, ultrasound and angio MRI data will be collected. Management wll be described as expectative, surgery or embolization of uterine arteries and the success or not will be noted. The investigators will question patients on their gynaecologic and obstetrical outcomes by telephone.

•Discussion: The investigators aim to define and characterize the different lesions, establish ultrasound criteria that would guide treatments. Describe the current treatments and compare them in terms of efficiency and safety in order to establish a homogeneous treatment protocol in our center

Full description

  • data are collected by computer software and patient phone calls
  • ultrasounds criteria are reviewed by two clinicians
  • statistical analysis is realized by a independent clinician
  • the consent and agreement of the ethics committee has been sought

Enrollment

64 patients

Sex

Female

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women
  • Aged between 18 and 50 years
  • Managed in CHU Montpellier
  • Diagnosis of hypervascularized products of conception
  • Available ultrasound pictures

Exclusion criteria

  • Subject unable to understand the study
  • Subject with another diagnosis of bleeding
  • Subject who have retained products of conception with no vascularity or immediate curettage with uterine vacuity
  • Subject who have no available ultrasound pictures

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems